Turn Therapeutics (TTRX)
Develops GX-03 for skin disease while licensing medical-device products.
$9.82
At close−0.00 (−0.05%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
estimated · in 70 days
EPS estimate
−$0.09
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
——Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported——−$0.07−$0.09−$0.03−$0.07−$0.20Pending
Estimate———−$0.05−$0.02−$0.02−$0.02−$0.09
Surprise———−76.5%−50.0%−250.0%−900.0%—
RevenueReportedEstimate
——Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.09 | — | — |
| Aug 2026 | −$0.02 | −$0.20 | −900.0% |
| Aug 2026 | −$0.02 | −$0.07 | −250.0% |
| May 2026 | −$0.02 | −$0.03 | −50.0% |
| Mar 2026 | −$0.05 | −$0.09 | −76.5% |
The latest year is open to everyone — the 1 quarter behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.09 | — | — | — | — | — | — |
| Aug 13, 2026 | −$0.02 | −$0.20 | −900.0% | — | — | — | −2.9% |
| Aug 12, 2026 | −$0.02 | −$0.07 | −250.0% | — | — | — | −6.5% |
| May 11, 2026 | −$0.02 | −$0.03 | −50.0% | — | — | — | +2.6% |
| Mar 31, 2026 | −$0.05 | −$0.09 | −76.5% | — | — | — | −2.5% |
The latest year is open to everyone — the 1 quarter behind it read with an account. Sign in | |||||||
| Nov 13, 2025 | |||||||